Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Chasing biotech, state by state—winners and losers

Nature Biotechnology volume 23, pages 175–179 (2005)Cite this article

An Erratum to this article was published on 01 April 2005

This article has been updated

States have identified biotech as an engine to economic prosperity. The obstacles for achieving success, however, especially for upstarts, may be considerable.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The rich get richer.

Mark Defeo

Figure 2: Genetown.

Change history

  • 01 April 2005

    Nat. Biotechnol. 23, 175–179 (2005) On page 178, paragraph 2, line 7, it was erroneously reported that “Rockefeller University (New York, NY, USA) still doesn't have a tech transfer office.” The university has had a tech transfer office since 2000.

References

  1. A survey of the use of biotechnology in US industry (US Department of Commerce, Technology Administration, Bureau of Industry and Security, Washington, DC, 2003).

  2. Resurgence: the Americas perspective. Global biotechnology report (Ernst & Young, New York, 2004).

  3. Beyond borders: global biotechnology report (Ernst & Young, New York, 2002).

  4. MoneyTree Survey: Investments by industry/Q2 2004 (PricewaterhouseCoopers, New York; Thomson Venture Economics, New York; and the National Venture Capital Association, Arlington, VA, 2004).

  5. Cortright, J. & Mayer, H. Signs of life: the growth of biotechnology centers in the US. (Brookings Institution Center on Urban and Metropolitan Policy, Washington, DC, 2002).

    Google Scholar 

Download references

Author information

Author notes

  1. Ken Howard Wilan is a contributing writer for Nature Biotechnology based in Boston, Massachusetts, USA.

Authors
  1. Ken Howard Wilan
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilan, K. Chasing biotech, state by state—winners and losers. Nat Biotechnol 23, 175–179 (2005). https://doi.org/10.1038/nbt0205-175

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0205-175

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing